Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results

13 Jun 2019

Abstract excerpt

Primary prevention of type 1 diabetes (T1D) requires intervention in genetically at-risk infants. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has established a screening program, GPPAD-02, that identifies infants with a genetic high risk of T1D, enrolls these into primary prevention trials, and follows the children for beta-cell autoantibodies and diabetes. Genetic testing is offered...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes and associated disorders
Share to Diabetes Management and Research
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31192505
DOI: 10.1111/pedi.12870

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first resultsPMID 31192505Read ↗

Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children.Semantic proximity Read ↗

The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.Semantic proximity Read ↗

Newborn screening for type 1 diabetes using genome-based risk scores in the Early Check program.Semantic proximity Read ↗

Genetics and its potential to improve type 1 diabetes care.Semantic proximity Read ↗

Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY)Semantic proximity Read ↗

Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions.Semantic proximity Read ↗

Genetics of type 1 diabetes.Semantic proximity Read ↗

HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk.Semantic proximity Read ↗

Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease.Semantic proximity Read ↗

Genetics of type 1 diabetesSemantic proximity Read ↗

Non-HLA risk variants in a type 1 diabetes pediatric population: Clinical and autoimmune profiles.Semantic proximity Read ↗

The Environmental Determinants of Diabetes in the Young (TEDDY) Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.